Inhibited differentiation of Langerhans cells in the rat epidermis upon systemic treatment with cyclosporin A

Histology and Histopathology

Volumn 16, Issue 1, 2001, Pages 107-112

  Borghi Cirri, M B ^a   Riccardi Arbi, R ^a   Bacci, S ^a   Mori, M ^a   Pimpinelli, N ^a   Romagnoli, P ^a   Fillipponi, F ^a  

^a Section E Allara   (Italy)

Author keywords

Differentiation; Electron microscopy; Immunohistochemistry; Monocytes

Indexed keywords

CYCLOSPORIN A; DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER RISK; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG BLOOD LEVEL; DRUG INHIBITION; ELECTRON MICROSCOPY; EPIDERMIS; GRANULE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LANGERHANS CELL; MALE; MONOCYTE; NONHUMAN; RAT; SKIN CANCER; VIRAL SKIN DISEASE;

ANIMALS; CELL DIFFERENTIATION; CYCLOSPORINE; EPIDERMIS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LANGERHANS CELLS; MALE; MICROSCOPY, ELECTRON; RATS; RATS, WISTAR; TISSUE EMBEDDING;

ANIMALIA;

EID: 0035151977     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Cyclosporine therapy for refractory Langerhans cell histiocytosis
2. Reduction in number and morphological alterations of Langerhans cells after UVB radiation are accompanied by an influx of monocytoid cells into the epidermis
3. The Langerhans cell in hairless mouse epidermis
4. Differentiation of monocytes into Langerhans cells in the human epidermis. An ultrastructural study
5. Differentiation of interdigitating reticulum cells and Langerhans cells in the human skin with T-lymphoid infiltrate. An immunohistochemical and ultrastructural study
6. Analysis of risk factors for cutaneous warts in renal transplant recipients
7. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study
8. Skin disease in immunosuppressed patients in relation to epidermal Langerhans' cells
9. Effects of ultraviolet radiation on human epidermal cell alloantigen presentation: Initial depression of Langerhans cell-dependent function is followed by the appearance of T6-Dr+ cells that enhance epidermal alloantigen presentation
10. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation
11. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis
12. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens
13. Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis
14. Interdigitating cells in the rat thymus during cyclosporin-A treatment: Ultrastructural observations
15. Alteration of dendritic cells in the rat thymus without epithelial cell loss during cyclosporine treatment and recovery
16. Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro
17. The optimum use of cyclosporin A in autoimmune diseases
18. Non-lymphoid cancer after liver transplantation
19. The effect of cyclosporine on epidermal Langerhans cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro
20. The steady-state turnover of murine epidermal Langerhans cells
21. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adults primary renal allograft recipients
22. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A
23. Cyclosporin A inhibits DNA synthesis by epidermal Langerhans cells
24. Reduction in murine Langerhans cell ATPase staining following topical but not systemic treatment with steroid and non-steroid immunosuppressants
25. Some new aspects of Langerhans cell
26. Cutaneous manifestations of renal transplantation in a New Zealand population
27. Differential effects of cyclosporine A on Langerhans cells and regulatory T-cell populations in severe psoriasis: An immunohistochemical and flow cytometric analysis
28. Class II antigen expression of epidermal Langerhans cells in renal allograft recipients
29. Alkaline phosphatase-positive Langerhans cells in the epidermis of cattle
30. Histological and ultrastructural effects of cyclosporin A on normal human skin xenografted on to nude mice
31. Treatment of relapsed Langerhans cell histiocytosis by cyclosporin A combined with etoposide and prednisone
32. Risk of neoplasia in renal transplant patients
33. Label-retaining keratinocytes and Langerhans cells in mouse epithelia
34. Cyclosporine therapy for advanced Langerhans cell histiocytosis
35. Immunophenotypic characterization of feline Langerhans cells
36. Dendritic cells in cutaneous lupus erythematosus: A hint to the pathogenesis of lesions
37. Association of basal-lamina defects with epidermal and dermal T6-positive cells: Evidence of Langerhans-cell migration
38. Immunohistochemical analysis of effects of cyclosporin A on gingival epithelium
39. Lack of demonstrable effect of cyclosporin A on human epidermal Langerhans cell function
40. Immunosuppressants: Tools to investigate the physiological role of cytokines
41. Integration of Langerhans cells into a pigmented reconstructed human epidermis
42. Morphology and membrane antigens of non-lymphoid accessory cells in oral hairy leukoplakia
43. A simple and rapid staining method for enhancing the contrast of tissues previously treated with uranyl acetate
44. Immunocompetent cells in oral candidiasis of HIV-infected patients: An immunohistochemical and electron microscopical study
45. Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells
46. Long-term benefits and risks of cyclosporin A (Sandimmun) - An analysis at 10 years
47. Langerhans cells in the development of skin cancer: A qualitative and quantitative comparison of cell markers in normal, acanthotic and neoplastic ovine skin
48. Cyclosporin A does not modify Langerhans' cell number and distribution in normal human skin
49. Cyclosporin A: Review of results in organ and bone-marrow transplantation in man